- Home
- KEYS vs NTRA Comparison
KEYS vs NTRA Comparison
Compare KEYS & NTRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KEYS
- NTRA
- Stock Information
- Founded
- KEYS 1939
- NTRA 2003
- Country
- KEYS United States
- NTRA United States
- Employees
- KEYS N/A
- NTRA N/A
- Industry
- KEYS Industrial Machinery/Components
- NTRA Medical Specialities
- Sector
- KEYS Industrials
- NTRA Health Care
- Exchange
- KEYS Nasdaq
- NTRA Nasdaq
- Market Cap
- KEYS 29.8B
- NTRA 27.0B
- IPO Year
- KEYS N/A
- NTRA 2015
- Fundamental
- Price
- KEYS $195.45
- NTRA $238.04
- Analyst Decision
- KEYS Buy
- NTRA Strong Buy
- Analyst Count
- KEYS 10
- NTRA 16
- Target Price
- KEYS $212.60
- NTRA $224.88
- AVG Volume (30 Days)
- KEYS 1.5M
- NTRA 1.8M
- Earning Date
- KEYS 11-24-2025
- NTRA 11-06-2025
- Dividend Yield
- KEYS N/A
- NTRA N/A
- EPS Growth
- KEYS 39.23
- NTRA N/A
- EPS
- KEYS 4.89
- NTRA N/A
- Revenue
- KEYS $5,375,000,000.00
- NTRA $2,116,676,000.00
- Revenue This Year
- KEYS $7.74
- NTRA $25.70
- Revenue Next Year
- KEYS $6.30
- NTRA $15.42
- P/E Ratio
- KEYS $40.00
- NTRA N/A
- Revenue Growth
- KEYS 7.95
- NTRA 38.17
- 52 Week Low
- KEYS $121.43
- NTRA $125.38
- 52 Week High
- KEYS $201.50
- NTRA $240.40
- Technical
- Relative Strength Index (RSI)
- KEYS 67.30
- NTRA 82.14
- Support Level
- KEYS $167.23
- NTRA $195.14
- Resistance Level
- KEYS $179.57
- NTRA $212.21
- Average True Range (ATR)
- KEYS 5.99
- NTRA 9.35
- MACD
- KEYS 0.34
- NTRA 2.78
- Stochastic Oscillator
- KEYS 82.35
- NTRA 96.00
About KEYS Keysight Technologies Inc.
Keysight Technologies is a leader in the field of testing and measurement, helping electronics OEMs and suppliers alike bring products to market to fit industry standards and specifications. Keysight specializes in the communications market, but also supplies into the government, automotive, industrial, and semiconductor manufacturing markets. Keysight's solutions include testing tools, analytical software, and services. The firm's stated objective is to reduce time to market and improve efficiency at its more than 30,000 customers.
About NTRA Natera Inc.
Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.